NovAccess Global Inc. (XSNX)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 02:42PM EDT
NovAccess Global Inc.
8584 E. Washington Street #127
Chagrin Falls, OH 44023
United States
213 642 9268
https://www.novaccessglobal.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 3
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Dwain K. Morris-Irvin M.P.H., MPH, Ph.D. | CEO & Director | 155.43k | N/A | 1968 |
| Mr. Neil J. Laird | Chief Financial Officer | N/A | N/A | 1953 |
| Dr. Christopher Wheeler Ph.D. | President of Stemvax Therapeutics | N/A | N/A | N/A |
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Description
NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.
Corporate Governance
NovAccess Global Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
© 2024 Yahoo. All rights reserved.